MEPO Trademark

Trademark Overview


On Thursday, May 23, 2013, a trademark application was filed for MEPO with the United States Patent and Trademark Office. The USPTO has given the MEPO trademark a serial number of 85941109. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 13, 2015. This trademark is owned by Glaxo Group Limited. The MEPO trademark is filed in the Pharmaceutical Products category with the following description:

(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines (Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the tr...
mepo

General Information


Serial Number85941109
Word MarkMEPO
Filing DateThursday, May 23, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 13, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 15, 2013

Trademark Statements


Goods and Services(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines (Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines (Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 5, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Trademark Events


Event DateEvent Description
Monday, July 13, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 13, 2015ABANDONMENT - NO USE STATEMENT FILED
Saturday, November 15, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 14, 2014EXTENSION 2 GRANTED
Wednesday, October 22, 2014EXTENSION 2 FILED
Friday, November 14, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 22, 2014TEAS EXTENSION RECEIVED
Thursday, May 22, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 20, 2014EXTENSION 1 GRANTED
Tuesday, May 20, 2014EXTENSION 1 FILED
Tuesday, May 20, 2014TEAS EXTENSION RECEIVED
Tuesday, December 10, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 15, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 15, 2013PUBLISHED FOR OPPOSITION
Wednesday, September 25, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 9, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, September 5, 2013ASSIGNED TO LIE
Thursday, September 5, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 28, 2013ASSIGNED TO EXAMINER
Wednesday, June 5, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 27, 2013NEW APPLICATION ENTERED IN TRAM